Introducing new cancer treatments: how reducing time to market access dramatically impacts patients’ lives (Guest blog)

In most European countries, reimbursement decision-making tends to drag on for months, sadly pushing the patient perspective further and further into the background. If cancer treatments would be available sooner, how many more patients could be treated? What would be the impact on their health and wellbeing? As part of the Time to Patient Initiative, Vintura and ASC Academics performed an impact analysis. Its findings leave no room for interpretation: for cancer patients, every day counts. Discover more about the Time to Patient Initiative >

Read the full blog

Bas Amesz

Bas Amesz is a Partner at Vintura.
Read Morechevron_right